openPR Logo
Press release

SWOT Analysis of mRNA Treatment Market Excessive Growth Opportunities Estimated to be Experienced by 2025 | CureVac, Moderna, BioNTech (Pfizer), Sanofi (Translate Bio), Kernal Biologics

07-31-2020 06:52 PM CET | Health & Medicine

Press release from: Business Industry Reports

mRNA Treatment Market

mRNA Treatment Market

The exclusive research report on the Global mRNA Treatment Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global mRNA Treatment Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Overview of Global mRNA Treatment Market:

This report studies the Global mRNA Treatment Market over the forecast period of 2020 to 2025. The Global mRNA Treatment Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2020 to 2025.

According to the market research study, mRNA is a versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use led to transient expression of the encoded protein. mRNA-based drugs have emerged as a highly attractive new class of biologics that encodes any protein of interest directly in vivo. The last two decades have been crucial in generating interest in various RNA based technologies. Clinical and preclinical trials in the field have led to positive responses facilitating increasing funding and investment by major pharmaceutical and biopharmaceutical companies. Clinical trials have proven that mRNA vaccines provide long lasting immune responses and are safe in animal and human models.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/273419 .

The Global mRNA Treatment Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global mRNA Treatment Market is sub-segmented into Vaccine, Drugs and others. On the basis of Application, the Global mRNA Treatment Market is classified into Protein Diseases, Gene Dysfunction Diseases and others.

In terms of the geographic analysis, the mRNA Treatment Market in North America is expected to grow at the highest CAGR during the forecast period. Moreover, the presence of major players in the mRNA Treatment Market ecosystem results in the increasing adoption of these systems in North America.

Global mRNA Treatment Market Objectives:

1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the mRNA Treatment Market

2 To analyze and forecast the size of the mRNA Treatment Market, in terms of value and volume

3 To analyze opportunities in the mRNA Treatment Market for stakeholders and provide a competitive landscape of the market

4 To define, segment, and estimate the mRNA Treatment Market based on deposit type and end-use industry

5 To strategically profile key players and comprehensively analyze their market shares and core competencies

6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market

7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America

8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the mRNA Treatment Market

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global mRNA Treatment Market Report 2020” @ https://www.businessindustryreports.com/buy-now/273419/single .

Top Leading Key Manufacturers are: CureVac, Moderna, BioNTech (Pfizer), Sanofi (Translate Bio), Ethris (AstraZeneca), Kernal Biologics, RaNA Therapeutics, Silence Therapeutics and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Latest Medical Industry News:

Sanofi (June 23, 2020) - Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas - Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have agreed to expand their existing 2018 collaboration and license agreement to develop mRNA vaccines for infectious diseases.

The expansion of this agreement will further unite Translate Bio’s expertise and knowledge from more than 10 years of mRNA research and development with Sanofi’s leadership in vaccine research and development. Under the expansion agreement, Translate Bio will receive a total upfront payment of $425 million, consisting of a $300 million cash payment and a private placement common stock investment of $125 million at $25.59 per share representing a 50 percent premium to the 20-day moving average share price prior to signing. Translate Bio will also be eligible for potential future milestones and other payments up to $1.9 billion, including $450 million of milestones under the 2018 agreement. Of these potential milestones and other payments, approximately $360 million are anticipated over the next several years, inclusive of COVID-19 vaccine development milestones. In addition, Translate Bio is also eligible to receive tiered royalty payments based upon worldwide sales of the developed vaccines. Sanofi Pasteur will pay for all costs during the collaboration term. Under this agreement Sanofi Pasteur will receive exclusive worldwide rights for infectious disease vaccines.

“As all eyes are on prevention of infectious disease through vaccines, this is a pointed moment in time where we are called upon to seek innovative ways to protect public health,” said Thomas Triomphe, Executive Vice President, Sanofi Pasteur. “We are excited by the novel technology and expertise Translate Bio brings, and we believe that adding this mRNA platform to our vaccines development capabilities will help us advance prevention against current and future infectious diseases.”

“The expansion of our collaboration with Sanofi Pasteur validates the progress we’ve made in the development of mRNA vaccines for infectious diseases since our work together began in 2018 and also speaks to the potential of our mRNA platform. We are excited to work with Sanofi in this broadened capacity with the goal of ultimately delivering vaccines on a global scale, a need underscored by the current pandemic,” said Ronald Renaud, Chief Executive Officer of Translate Bio. “Translate Bio will also be well positioned financially to continue to build upon our internal capabilities with a focus on advancing innovations in platform discovery and on the development of ongoing and additional preclinical therapeutic programs as we aim to bring multiple programs towards clinical development.”

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of mRNA Treatment in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/273419 .

Major Points in Table of Contents:

Global mRNA Treatment Market Report 2020

1 mRNA Treatment Product Definition

2 Global mRNA Treatment Market Manufacturer Share and Market Overview

2.1 Global Manufacturer mRNA Treatment Shipments

2.2 Global Manufacturer mRNA Treatment Business Revenue

2.3 Global mRNA Treatment Market Overview

2.4 COVID-19 Impact on mRNA Treatment Industry

3 Manufacturer mRNA Treatment Business Introduction

3.1 CureVac mRNA Treatment Business Introduction

3.2 Moderna mRNA Treatment Business Introduction

3.3 BioNTech (Pfizer) mRNA Treatment Business Introduction

3.4 Sanofi (Translate Bio) mRNA Treatment Business Introduction

3.5 Ethris (AstraZeneca) mRNA Treatment Business Introduction

3.6 Kernal Biologics mRNA Treatment Business Introduction

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SWOT Analysis of mRNA Treatment Market Excessive Growth Opportunities Estimated to be Experienced by 2025 | CureVac, Moderna, BioNTech (Pfizer), Sanofi (Translate Bio), Kernal Biologics here

News-ID: 2101228 • Views: 575

More Releases from Business Industry Reports

2020-2025 Neoantigen Targeted Therapies Market to witness astonishing growth wit …
Global Neoantigen Targeted Therapies Market Synopsis: The report covers a forecast and an analysis of the Neoantigen Targeted Therapies Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Neoantigen Targeted Therapies Market along with the impact they have
Outstanding Scope of Nasojejunal Tube Market is Estimated to Grow Incredible CAG …
Overview of Global Nasojejunal Tube Market: This report provides in-depth study of “Global Nasojejunal Tube Market 2020” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Nasojejunal Tube Market report also provides an in-depth survey of key players in the market organization. The 'Global Nasojejunal Tube Industry, Market Research Report' is a professional and in-depth study on the current state of the global Nasojejunal Tube Market with a
Huge Investment in mTOR Inhibitors Market Expected to Witness the Highest Growth …
Global mTOR Inhibitors Market Synopsis: The exclusive research report on the Global mTOR Inhibitors Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global mTOR Inhibitors Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. According to the market research study, Mammalian Target Of Rapamycin (mTOR) is
Mobile Cardiac Telemetry Systems Market to Exhibit Impressive Growth by 2025: In …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Mobile Cardiac Telemetry Systems Market” Research Report 2020 provides an in-depth analysis of the Mobile Cardiac Telemetry Systems with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Mobile Cardiac Telemetry

All 5 Releases


More Releases for RNA

RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
RNA Analysis Market worth 3.62 billion USD by 2021
RNA Analysis Market size was around USD 1.89 billion in 2016. It is expected to grow at a CAGR of 13.9% to reach USD 3.62 billion by 2021. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led